MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fisher, S. K.
Right arrow Articles by Roland, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fisher, S. K.
Right arrow Articles by Roland, R. M.

Muscarinic receptor regulation of cytoplasmic Ca2+ concentrations in human SK-N-SH neuroblastoma cells: Ca2+ requirements for phospholipase C activation

SK Fisher, LM Domask and RM Roland

Neuroscience Laboratory, University of Michigan, Ann Arbor 48104-1687.

The relationship between muscarinic receptor-mediated inositol lipid hydrolysis and the generation of Ca2+ signals has been examined in human SK-N-SH neuroblastoma cells. The resting cytoplasmic calcium concentration [( Ca2+]i) as determined by fura-2 fluorescence measurements was 59 +/- 2 nM. Upon the addition of oxotremorine-M, there was a 4-fold increase in [Ca2+]i (293 +/- 18 nM), with half- maximal stimulation obtained at an agonist concentration of 8 microM, a value similar to that previously observed for the enhancement of phosphoinositide hydrolysis. Addition of partial muscarinic agonists for phosphoinositide turnover (bethanechol, oxo-2, and arecoline) elicited correspondingly smaller increases in [Ca2+]i than did oxotremorine-M. Inclusion of EGTA lowered the basal [Ca2+]i within 2 min and markedly reduced (greater than 60%) the magnitude of the agonist-induced rise in [Ca2+]i. Addition of muscarinic agonists to SK- N-SH cells that had been prelabeled with [3H]inositol led to the rapid (5-15 sec) release of inositol mono-, bis-, and triphosphates. When assayed under conditions similar to those employed for the fluorescence measurements, EGTA also inhibited both the basal and oxotremorine-M- stimulated release of inositol phosphates by 45-61%. Conversely, ionomycin both elevated [Ca2+]i and stimulated the release of inositol phosphates. The addition of Ca2+ (10 nM-2 microM) to digitonin- permeabilized cells directly stimulated the release of labeled inositol mono-, bis-, and trisphosphates by 3-4-fold with a half-maximal effect (EC50) observed at 145 nM free Ca2+ (Ca2+f). A further (6-fold) calcium- dependent increase in inositol phosphate release was obtained by inclusion of either guanosine-5-O-(3-thio)-trisphosphate (GTP gamma S) or oxotremorine-M. In the combined presence of agonist and GTP gamma S, a synergistic release of all three inositol phosphates occurred, with half-maximal stimulation observed at 35-40 nM Ca2+f, a value similar to the [Ca2+]i in quiescent cells. These results indicate (i) that the magnitude of the initial rise in [Ca2+]i is directly related to the production of phosphoinositide-derived second messenger molecules and (ii) that the phospholipase C-mediated breakdown of inositol lipids in SK-N-SH cells is particularly sensitive to regulation by physiologically relevant Ca2+ concentrations. It is concluded that, in SK-N-SH cells, either an elevation above or reduction below basal [Ca2+]i can modulate the extent of hydrolysis of inositol lipids and the subsequent generation of calcium signals.

Volume 35, Issue 2, pp. 195-204, 02/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Wada, C. J. DeLong, Y. H. Hong, C. J. Rieke, I. Song, R. S. Sidhu, C. Yuan, M. Warnock, A. H. Schmaier, C. Yokoyama, et al.
Enzymes and Receptors of Prostaglandin Pathways with Arachidonic Acid-derived Versus Eicosapentaenoic Acid-derived Substrates and Products
J. Biol. Chem., August 3, 2007; 282(31): 22254 - 22266.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Cheema, V. A. Pettigrew, and S. K. Fisher
Receptor Regulation of the Volume-Sensitive Efflux of Taurine and Iodide from Human SH-SY5Y Neuroblastoma Cells: Differential Requirements for Ca2+ and Protein Kinase C
J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1068 - 1077.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. M. Heacock, D. J. Foster, and S. K. Fisher
Prostanoid Receptors Regulate the Volume-Sensitive Efflux of Osmolytes from Murine Fibroblasts via a Cyclic AMP-Dependent Mechanism
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 963 - 971.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. M. Heacock, M. S. Dodd, and S. K. Fisher
Regulation of Volume-Sensitive Osmolyte Efflux from Human SH-SY5Y Neuroblastoma Cells following Activation of Lysophospholipid Receptors
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 685 - 693.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Cheema, C. E. Ward, and S. K. Fisher
Subnanomolar Concentrations of Thrombin Enhance the Volume-Sensitive Efflux of Taurine from Human 1321N1 Astrocytoma Cells
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 755 - 763.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
L. F. Horowitz, W. Hirdes, B.-C. Suh, D. W. Hilgemann, K. Mackie, and B. Hille
Phospholipase C in Living Cells: Activation, Inhibition, Ca2+ Requirement, and Regulation of M Current
J. Gen. Physiol., August 29, 2005; 126(3): 243 - 262.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Kantor, M. Zhang, B. Guptaroy, Y. H. Park, and M. E. Gnegy
Repeated Amphetamine Couples Norepinephrine Transporter and Calcium Channel Activities in PC12 Cells
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1044 - 1051.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. T. Nieman, M. Warnock, A. A. K. Hasan, F. Mahdi, B. R. Lucchesi, N. J. Brown, L. J. Murphey, and A. H. Schmaier
The Preparation and Characterization of Novel Peptide Antagonists to Thrombin and Factor VIIa and Activation of Protease-Activated Receptor 1
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 492 - 501.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. E. Gnegy, H. Khoshbouei, K. A. Berg, J. A. Javitch, W. P. Clarke, M. Zhang, and A. Galli
Intracellular Ca2+ Regulates Amphetamine-Induced Dopamine Efflux and Currents Mediated by the Human Dopamine Transporter
Mol. Pharmacol., July 1, 2004; 66(1): 137 - 143.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Kantor, G. H. K. Hewlett, Y. H. Park, S. M. Richardson-Burns, M. J. Mellon, and M. E. Gnegy
Protein Kinase C and Intracellular Calcium Are Required for Amphetamine-Mediated Dopamine Release via the Norepinephrine Transporter in Undifferentiated PC12 Cells
J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1016 - 1024.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Apparsundaram, A. Galli, L. J. DeFelice, H. C. Hartzell, and R. D. Blakely
Acute Regulation of Norepinephrine Transport: I. Protein Kinase C-Linked Muscarinic Receptors Influence Transport Capacity and Transporter Density in SK-N-SH Cells
J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 733 - 743.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. C. Resendes, G. C. Kalogeros, S. J. Dixon, and R. B. Philp
Nitrous Oxide Enhances Na+/Ca++Exchange in the Neuroblastoma Cell Line SK-N-SH
J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 795 - 801.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
X. Li, L. Song, and R. S. Jope
Cholinergic Stimulation of AP-1 and NFkappa B Transcription Factors Is Differentially Sensitive to Oxidative Stress in SH-SY5Y Neuroblastoma: Relationship to Phosphoinositide Hydrolysis
J. Neurosci., October 1, 1996; 16(19): 5914 - 5922.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. A.K. Hasan, S. Amenta, and A. H. Schmaier
Bradykinin and Its Metabolite, Arg-Pro-Pro-Gly-Phe, Are Selective Inhibitors of {alpha}-Thrombin–Induced Platelet Activation
Circulation, August 1, 1996; 94(3): 517 - 528.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics